Table 2 General characteristics and demographics of the pre-implementation and post-implementation cohort
Pre-implementation cohort (n = 160) | Post-implementation cohort (n = 160) | P value | ||
|---|---|---|---|---|
Age | Mean value (SD) | 58.2 (± 22.1) | 59.8 (± 17.7) | 0.854 |
Sex | Female | 51.9% | 49.4% | 0.655 |
Average number of prescriptions per patient | Mean value (SD) | 11.6 (± 5.6) | 10.0 (± 3.3) | n.a. |
All prescriptions | n (%) | 1850 (100%) | 1592 (100%) | 0.009 |
Standard peroral prescriptions | n (%) | 1051 (56.8%) | 990 (62.2%) | 0.673 |
Prescriptions with a risky administration route | n (%) | 265 (14.3%) | 200 (12.6%) | 0.117 |
Prescriptions as needed | n (%) | 452 (24.4%) | 362 (22.7%) | 0.012 |
Other prescription | n (%) | 82 (4.4%) | 40 (2.5%) | 0.002 |